// App-Quantinova.ai

391 : Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.

Researchers

Presenter

  • Julien Taieb

Principal Investigators

  • Pascal Hammel

  • Michele Reni

  • Daniel H. Palmer

  • John A. Bridgewater

  • Antonio Cubillo

  • Gerald W. Prager

  • Alice Vermeire

  • Nathalie D'Esquermes

  • Fabienne Biville-Hedouin

  • Zhaoyang Teng

  • Thomas Seufferlein

  • Teresa Macarulla

Medical Centers

  • Georges Pompidou Hospital, Paris, France

  • Hopital Beaujon, Clichy, France

  • San Raffaele Scientific Institute, Milan, Italy

  • University of Liverpool, Liverpool, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • HM CIOCC, Madrid, Spain

  • Medical University of Vienna, Vienna, Austria

  • Global Medical Affairs Oncology, Servier, Suresnes, France

  • Genactis, Mougins, France

  • Servier, Suresnes, France

  • Servier Pharmaceuticals, Boston

  • Department of Medicine I, Hospital of the University Ulm, Ulm, Germany

  • Hospital Universitario del Mar, Barcelona, Spain

Locations

  • France

  • Italy

  • United Kingdom

  • Spain

  • Austria

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved